Fosun International’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,714
Closed -$863K 327
2019
Q1
$863K Buy
+20,714
New +$863K 0.05% 175